Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLC.
Journal: Clinical lung cancer
Published: October 30, 2025
First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors.
First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2025
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 02, 2025
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
Journal: Cancer immunology, immunotherapy : CII
Published: August 31, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade.
Journal: Cancer research communications
Published: July 26, 2022
Model-based meta-analysis of non-small cell lung cancer with standard of care PD-1 inhibitors and chemotherapy for early development decision making.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 23, 2022
Immuno-PET Monitoring of CD8+ T Cell Infiltration Post ICOS Agonist Antibody Treatment Alone and in Combination with PD-1 Blocking Antibody Using a 89Zr Anti-CD8+ Mouse Minibody in EMT6 Syngeneic Tumor Mouse.
Journal: Molecular imaging and biology
Published: May 29, 2022
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.
Journal: Leukemia & lymphoma
Published: December 20, 2021
Immunodynamics of explanted human tumors for immuno-oncology.
Journal: EMBO molecular medicine
Published: May 30, 2020
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.
Journal: Translational lung cancer research
Published: August 02, 2019
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 06, 2019
Last Updated: 09/26/2026